2025年12月30日到期的Oragens股份封存协议允许限制性股票销售。 Lock-up agreements for Oragenics shares expire December 30, 2025, allowing restricted stock sales.

公司官员,董事和主要股东持有的Oragenics,Inc.股票,期权和担保的锁定协议将于2025年12月30日到期,此前该公司的181天限制从2025年7月2日开始. Lock-up agreements for Oragenics, Inc. shares, options, and warrants held by officers, directors, and major shareholders expire on December 30, 2025, following an 181-day restriction that began July 2, 2025. 这些限制与计划书挂钩,目的是在公开出价后稳定股票价格,防止出售或转让这些证券。 The restrictions, tied to a prospectus and aimed at stabilizing the stock price after a public offering, prevent the sale or transfer of these securities. 股票到期时,可以按照证券条例进行交易。 Upon expiration, the shares may be traded in compliance with securities regulations.